Insulet Corp (PODD) community

PODDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 21/3046% below fair value

$149.29−0.74 (-0.49%)

Close on Nov 12, 2026Market cap $10.35BP/E 24.3Yield –

Community

Notes and questions about Insulet from other investors

No posts about PODD yet

Discussion is coming to every stock. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Where these numbers come from

Parsed from the XBRL in Insulet's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PODD.

Compare: PODD vs MMED · PODD vs TNDM · PODD vs DXCM · PODD vs ICUI · PODD vs TFX

Revenue growth26.5% · median 13.0%

Gross margin71.9% · median 56.6%

Operating margin18.4% · median 5.1%

Net margin13.4% · median 2.8%

Company	Revenue	Growth
DXCM	$5.10B	+13.0%
PODD	$3.19B	+26.5%
MMED	$3.10B	+14.3%
TFX	$2.26B	+20.9%
ICUI	$2.18B	-5.9%
TNDM	$1.08B	+6.8%

Company

Next earnings (est.): Feb 17, 2027, before open
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 5,400
Held by institutions: 100.0%
Auditor: GRANT THORNTON LLP
SEC CIK: 1145197

Advertisement
300 × 250

See a number that looks wrong?